Finally: A New Psychotropic Drug in Germany – Cariprazine

Recordati launched the new antipsychotic cariprazine in Germany in Mid-April. The benefit assessment by the G-BA has therefore started.

Antipsychotics for long-term treatment – when to stop? Or better not?

A new publication in the prestigious Lancet Psychiatry seems to provide new evidence for the benefits of long-term antipsychotic maintenance treatment in schizophrenia (Hui et al., Lancet Psychiatry 2018). On closer inspection, however, the paper confuses more than it provides new insights.